Patents-Review.com
🔗 Permalink
Assignee profile:

Domantis Limited

City:

Cambridge

Country:

United Kingdom

Published Applications:

22

Last publication date:

2013-09-05

Patent Grants:

9

Last grant date:

2011-04-19

Top Inventors for applications by Domantis Limited

These are the the leading inventors for applications assigned to Domantis Limited:

Recent patent applications by Domantis Limited

Domantis Limited based in Cambridge, GB has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2013-09-05
US20130230540A1
Chemistry; metallurgy

COMPOSITIONS MONOVALENT FOR CD28 BINDING AND METHODS OF USE

 #2 | 2013-08-22
US20130216538A1
Chemistry; metallurgy

Compositions and Methods for Treating Inflammatory Disorders

 #3 | 2011-07-14
US20110172400A1
Chemistry; metallurgy

COMPOSITIONS MONOVALENT FOR CD40L BINDING AND METHODS OF USE

 #4 | 2011-04-28
US20110097339A1
Chemistry; metallurgy

Compositions monovalent for CD28 binding and methods of use

 #5 | 2010-04-15 ✅ Patent 7,927,596 granted on 2011-04-19
US20100092483A1
Chemistry; metallurgy

Methods of antagonizing binding of CD40 to CD40L with CD40L-specific monovalent polypeptides

 #6 | 2010-04-15 ✅ Patent 7,829,096 granted on 2010-11-09
US20100092482A1
Chemistry; metallurgy

CD40L-specific monovalent polypeptides

 #7 | 2010-03-04
US20100056439A1
Chemistry; metallurgy

LIGANDS THAT HAVE BINDING SPECIFICITY FOR EGFR AND/OR VEGF AND METHODS OF USE THEREFOR

 #8 | 2010-01-28
US20100021473A1
Chemistry; metallurgy

Bispecific Ligands With Binding Specificity to Cell Surface Targets and Methods of Use Therefor

 #9 | 2009-12-03 ✅ Patent 8,524,236 granted on 2013-09-03
US20090297524A1
Chemistry; metallurgy

Methods of antagonizing the binding of CD40 to CD40L with CD40L-specific monovalent polypeptides in autoimmune individuals

 #10 | 2009-10-15
US20090258012A1
Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR TREATING INFLAMMATORY DISORDERS

 #11 | 2009-08-13 ✅ Patent 8,680,018 granted on 2014-03-25
US20090203542A1
Chemistry; metallurgy

Selection system

 #12 | 2009-07-09 ✅ Patent 8,084,213 granted on 2011-12-27
US20090176209A1
Chemistry; metallurgy

Selection

 #13 | 2009-04-30
US20090111745A1
Chemistry; metallurgy

Plad Domain Peptides With Increased Serum Half Life Due To Conjugation To Domain Antibodies

 #14 | 2008-10-28 ✅ Patent 7,442,159 granted on 2008-10-28
US9710444
-

Selection system

 #15 | 2008-10-02
US20080241166A1
Chemistry; metallurgy

Ligands that bind a receptor

 #16 | 2008-02-14
US20080038735A1
Chemistry; metallurgy

Tus DNA binding domains

 #17 | 2008-01-10
US20080008713A1
Chemistry; metallurgy

Single domain antibodies against tnfr1 and methods of use therefor

 #18 | 2007-05-17
US20070111282A1
Chemistry; metallurgy

Method to screen phage display libraries with different ligands

 #19 | 2007-02-01 ✅ Patent 7,846,721 granted on 2010-12-07
US20070026462A1
Chemistry; metallurgy

GAS1 universal leader

 #20 | 2006-03-23 ✅ Patent 7,563,443 granted on 2009-07-21
US20060062784A1
Chemistry; metallurgy

Monovalent anti-CD40L antibody polypeptides and compositions thereof

 #21 | 2006-01-05
US20060002935A1
Chemistry; metallurgy

Tumor Necrosis Factor Receptor 1 antagonists and methods of use therefor

 #22 | 2005-01-25 ✅ Patent 6,846,634 granted on 2005-01-25
US9511939
-

Method to screen phage display libraries with different ligands
AssigneeID:

35852 ⎘